ZDHHC5-mediated NLRP3 palmitoylation promotes NLRP3-NEK7 interaction and inflammasome activation
Molecular Cell · 2023-12 · 83 (24) · 4570-4585.e7
DOI: 10.1016/j.molcel.2023.11.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2023-12. Verfasst von Sihao Zheng und 14 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Inflammasomes, NLR Family, Pyrin Domain-Containing 3 Protein, Acyltransferases. Die Arbeit wurde bisher 162-mal zitiert (Crossref) und nennt 74 Literaturangaben.
Abstract (Originalsprache)
The nucleotide-binding domain (NBD), leucine-rich repeat (LRR), and pyrin domain (PYD)-containing protein 3 (NLRP3) inflammasome is a critical mediator of the innate immune response. How NLRP3 responds to stimuli and initiates the assembly of the NLRP3 inflammasome is not fully understood. Here, we found that a cellular metabolite, palmitate, facilitates NLRP3 activation by enhancing its S-palmitoylation, in synergy with lipopolysaccharide stimulation. NLRP3 is post-translationally palmitoylated by zinc-finger and aspartate-histidine-histidine-cysteine 5 (ZDHHC5) at the LRR domain, which promotes NLRP3 inflammasome assembly and activation. Silencing ZDHHC5 blocks NLRP3 oligomerization, NLRP3-NEK7 interaction, and formation of large intracellular ASC aggregates, leading to abrogation of caspase-1 activation, IL-1β/18 release, and GSDMD cleavage, both in human cells and in mice. ABHD17A depalmitoylates NLRP3, and one human-heritable disease-associated mutation in NLRP3 was found to be associated with defective ABHD17A binding and hyper-palmitoylation. Furthermore, Zdhhc5-/- mice showed defective NLRP3 inflammasome activation in vivo. Taken together, our data reveal an endogenous mechanism of inflammasome assembly and activation and suggest NLRP3 palmitoylation as a potential target for the treatment of NLRP3 inflammasome-driven diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China.
- Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China; Department of Oncology, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA.
- Department of Oncology, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA.
- Department of Gastroenterology and Hepatology, Renmin Hospital of Wuhan University, Wuhan, China.
- Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China. Electronic address: qibinsong@whu.edu.cn.
- Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, China. Electronic address: juanjuan.li@whu.edu.cn.
Zitieren
APA
Zheng, S., Que, X., Wang, S., Zhou, Q., Xing, X., Chen, L., Hou, C., Ma, J., An, P., Peng, Y., Yao, Y., Song, Q., Li, J., Zhang, P., & Pei, H. (2023). ZDHHC5-mediated NLRP3 palmitoylation promotes NLRP3-NEK7 interaction and inflammasome activation. Molecular Cell, 83(24), 4570-4585.e7. https://doi.org/10.1016/j.molcel.2023.11.015
Vancouver
Zheng S, Que X, Wang S, Zhou Q, Xing X, Chen L, et al. ZDHHC5-mediated NLRP3 palmitoylation promotes NLRP3-NEK7 interaction and inflammasome activation. Molecular Cell. 2023;83(24):4570-4585.e7. doi:10.1016/j.molcel.2023.11.015
BibTeX
@article{Zheng2023,
author = {Zheng, Sihao and Que, Xiangyong and Wang, Shuxian and Zhou, Qi and Xing, Xiaoke and Chen, Liang and Hou, Chunyan and Ma, Junfeng and An, Ping and Peng, Yihan and Yao, Yi and Song, Qibin and Li, Juanjuan and Zhang, Pingfeng and Pei, Huadong},
title = {ZDHHC5-mediated NLRP3 palmitoylation promotes NLRP3-NEK7 interaction and inflammasome activation},
journal = {Molecular Cell},
year = {2023},
volume = {83},
number = {24},
pages = {4570--4585.e7},
doi = {10.1016/j.molcel.2023.11.015}
}
EUVIMED